Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“Dr. Wayne Jonas, who reviewed antineoplastons for NCI, the drugs probably have a lower toxicity than some chemotherapies prescribed for brain cancer.”
I can’t tell you if Antineoplaston Therapy (ANP) produced by the Burzynski Research Institute (BRI) is legit or not. All I can tell you with absolute certainty is that I underwent conventional standard-of-care multiple myeloma therapy from my diagnosis of MM from 2/94- 9/97.
After remission, relapse, remission and relapse, I reached end-stage, was told “nothing more could be done for me” by my oncologist, Dr. Anne Rassiga on September 30th, 1997.
I began ANP A2-1, A10, on November 3 of that year. I underwent intravenous ANP for the next 10 months, capsules for seven months after that. I reached complete remission aka cancer-free status where I have remained ever since.
I can tell you with absolute certainty that:
I can also tell you with absolute certainty that:
I understand why the FDA and conventional oncology approaches MM the way it does. The FDA works hard to limit non-conventional cancer therapies. That’s the way the FDA works in the United States.
But I also understand that oncology, especially multiple myeloma oncology is a huge business in the United States. I also understand that conventional MM therapies cannot cure multiple myeloma.
Multiple Myeloma patients and survivors should be able to choose any therapy that they want- conventional, ANP, spiritual, hell, even “laying on of hands” if they want to.
I don’t expect conventional health insurance or Medicare/Medicaid to cover the cost of ANP (or laying on of hands…).
But I do expect State (Texas Medical Board) and the Federal Government to leave Burzynski alone. Let MM patients choose whatever therapy they want.
That’s just my opinion…
Scroll down to the bottom of the page and post a question or a comment. I will reply to you ASAP.
The board alleges that Burzynski charged “exorbitant” amounts, billed for unnecessary tests, and failed to adequately disclose his stake in the pharmacy and laboratory that provided many patients’ drugs and tests. Perhaps even more worrying, the board says Burzynski and his staff made numerous medical and record-keeping errors, including misinterpreting scans and using the wrong tests to evaluate patients’ progress. Then there are the untested drug combinations. On its website, the Burzynski Clinic says it offers “personalized cancer therapy,” using genetic analysis to customize treatment for each patient. But in expert testimony for the medical board, Dr. Cynthia Wetmore, director of the program in Developmental Therapeutics in the Aflac Cancer and Blood Disorders Center in Atlanta, said, “There’s not a possible way to tell what drug is helping and what drug is not helping. The drugs are given in nonstandard combinations that never have been tested. They’re given in nonstandard doses that are not known to be effective or safe. And combining them is experimenting on humans, which cannot be done outside a clinical study. That’s unethical.“
The board concluded that because of Burzynski’s actions and those of his subordinates, “each of the patients in this case either suffered considerable toxicity effects or were put at significant risk of considerable toxicity effects…”
Burzynski takes a different view—he says the drug combinations are evidence of his innovative approach to medicine…
Burzynski argued that it’s unfeasible to restrict practitioners only to tested drug combinations, because with almost 100 cancer drugs, testing every combination of five agents would result in “hundreds of thousands of trials…”
Because of the lack of strong scientific evidence, there is little concrete information about the toxicity or side effects of the drugs. On the one hand, says Dr. Wayne Jonas, who reviewed antineoplastons for NCI, the drugs probably have a lower toxicity than some chemotherapies prescribed for brain cancer. But on the other, studies of antineoplastons have observed serious side effects, including severe neurological toxicity, bone marrow suppression, hypernatremia, fatigue, stupor and coma, and potassium deficiency in the blood…
As far back as 1994, an FDA inspection found that Burzynski was misrepresenting side effects as minimal. Eighteen years later, a 6-year-old boy in one of Burzynski’s trials died with hypernatremia. When the FDA found out, they put a partial hold on his trials, forbidding him from enrolling children. Later, the agency expanded the hold to include adults…
At this point, Dye knew something about antineoplastons, and the scant evidence of their efficacy. Still, she fulfilled the family’s wishes, returning to New Hampshire and administering the antineoplastons. The drugs were debilitating, causing hypernatremia that led to anemia and sleepiness. Every day, she and the family debated whether to continue, knowing that this could be the girl’s last summer. After a few weeks, the family discontinued the treatment, and a few months later the girl passed away. Dye says the clinic never followed up with the family, either before or after the girl’s passing…
After two years of Ping-Ponging records and paperwork with Burzynski, in June 2014, the FDA decided that the doctor’s submissions to the agency had finally addressed its concerns around poor documentation, and it lifted the clinical hold…
Chatting with supporters during a break in his Texas Medical Board hearing in November, Burzynski also struck a conspiratorial note, saying of the board, “They’re working for big institutions, and their business is to get rid of the people who really are trying to do something on their own, without taking tons of government money.” He said the board was trying to shield major cancer research bodies from tough questions about why he had succeeded where they had failed. “They are spending billions of dollars, and in a city like Houston we are the only ones who have come up with the discovery of an original anti-cancer medicine…”
Given this startlingly frank admission, many critics ask why Burzynski is still allowed to run his clinic and to enroll patients in trials. “The FDA has inspected him quite a few times, and they always find stuff, but they never can quite seem to shut down his clinical trials,” says David Gorski, a surgical oncologist at the Barbara Ann Karmanos Cancer Institute, and a blogger who’s written extensively about Burzynski.
Gorski says he’s asked the FDA why it hasn’t shut down Burzynski, and they’ve never explained. When Newsweek asked the agency the same question, it responded with a general statement, making no reference to Burzynski, saying simply that it takes action based on its most recent inspections, using all available information...
Meanwhile, Burzynski has vowed to keep fighting. The medical board hearing was due to wrap up in January, but after Burzynski was diagnosed with a heart condition, his lawyers successfully campaigned to put off the remainder of the trial to May. For his supporters and critics, the delay is nothing new—just another temporary cease-fire in a conflict that’s gone on for four decades…”